Curie Therapeutics Funding: $75M Raised, Series A (2021)
Curie Therapeutics is based in Cambridge, Mass.. It has raised $75M in total funding. Latest round: Series A.
Curie Therapeutics funding overview
Curie Therapeutics is based in Cambridge, Mass.. Curie Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2021. The round record for Curie Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Access Biotechnology, Atlas Venture, Endeavor Venture Funds, OAK HC/FT, Tachyon Ventures, VenBio Partners. 6 distinct backers are named across the disclosed rounds.
Curie Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Curie Therapeutics?
Access Biotechnology, Atlas Venture, Endeavor Venture Funds, OAK HC/FT, Tachyon Ventures, VenBio Partners are named among the investors backing Curie Therapeutics.
What was the latest Curie Therapeutics funding round?
The most recent disclosed round is a Series A, announced in November 2021.
Where is Curie Therapeutics based?
Curie Therapeutics is based in Cambridge, Mass..
When did Curie Therapeutics last raise?
The last disclosed Curie Therapeutics round closed in November 2021 at Series A.
We update the Curie Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
